Mitochondrial electron transport chain and cellular redox systems (ETC/Redox systems)

The mitochondrial electron transport chain (ETC) and cellular redox systems are central to cellular energy production and the maintenance of chemical balance within the cell. The ETC consists of five primary protein complexes (Complex I-V) located in the inner mitochondrial membrane that facilitate the transfer of electrons to oxygen, creating a proton gradient used to synthesize ATP [1][2]. Cellular redox systems, including the glutathione and thioredoxin pathways, work alongside the ETC to manage reactive oxygen species (ROS) and maintain the reduction-oxidation state necessary for protein function and signaling [3]. Dysregulation of these systems is implicated in a wide range of diseases, including neurodegenerative conditions like Parkinson's disease, where mitochondrial dysfunction is a primary driver, and cancer, where metabolic shifts support rapid proliferation [4][5]. Therapeutic strategies targeting these systems range from the use of Metformin to inhibit Complex I for metabolic control to the application of mitochondrial-targeted antioxidants like MitoQ to reduce oxidative damage [6]. However, because these systems are essential for nearly all cell types, pharmacological intervention carries significant risks of systemic toxicity and metabolic side effects such as lactic acidosis [7].

Other names

Mitochondrial respiratory chainOxidative phosphorylation systemOXPHOSCellular antioxidant systemsMitochondrial energy metabolism

Inhibition of electron transport complexes (e.g., Complex I), uncoupling of oxidative phosphorylation, scavenging of reactive oxygen species, and replenishment of cellular antioxidant pools (e.g., glutathione).